Case Report
Copyright ©The Author(s) 2024.
World J Clin Cases. Aug 26, 2024; 12(24): 5589-5595
Published online Aug 26, 2024. doi: 10.12998/wjcc.v12.i24.5589
Figure 3
Figure 3 Follow-up procedure. A and B: Changes in total bilirubin (TBIL) and platelets (PLT) in the patient during the treatment process; C: Hydroxyurea (500 mg 2/d) was self-discontinued after 1 mo; D: Acetate prednisone tablets were reduced by 5 mg after the first 2 wk, followed by a weekly reduction of 5 mg. The patient self-discontinued the medication after 3 mo of use.